세계의 마이크로 RNA(MicroRNA) 연구 툴 시장 규모는 2023년 6억 6,420만 달러에서 예측 기간 동안 5.9%의 CAGR을 나타내고, 2028년에는 8억 8,300만 달러 규모에 이를 것으로 예상됩니다.
마이크로 RNA 기반 정량적 역전사 PCR(RT-qPCR) 부문은 2023년 21억 1,000만 달러에서 2028년 27억 2,200만 달러로 연평균 5.6% 성장할 것으로 예측됩니다. 또한, 마이크로 RNA 기반 차세대 시퀀싱(NGS) 기술 부문은 2023년 1억 4,110만 달러에서 예측 기간 동안 7.6%의 CAGR로 2028년 2억 4,000만 달러로 성장할 것으로 예측됩니다.
본 보고서는 마이크로 RNA 연구 툴, 진단 및 치료제 시장을 조사했으며, 시장 배경과 개요, 시장 영향요인 분석, 시장 규모 추이 및 예측, 각 부문별/지역별 상세 분석, ESG 전개, 신기술 및 신흥 동향, 파이프라인 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 서론
제2장 요약 및 하이라이트
제3장 시장 개요
- 배경 : 유전 물질
- RNA의 유형
- Messenger RNA (mRNA)
- Ribosomal RNA (rRNA)
- Transfer RNA (tRNA)
- Small Interfering RNAs (siRNA)
- Small Nucleolar RNA (snoRNA)
- PIWI-interacting RNAs (piRNAs)
- MicroRNAs (miRNAs)
- 개요
- 마이크로 RNA 연구 역사
- 마이크로 RNA의 생합성
- 마이크로 RNA의 기능
- 마이크로 RNA의 응용
- 연구 툴
- 치료 마이크로 RNA
- 진단 마이크로 RNA
- 바이오인포매틱스 : 마이크로 RNA 연구 응용
- 계산 툴
- miRDB
- TargetScan
- DIANA-microT-CDS
- miRTargetLink 2.0
- RNA22 v2
- TargetMiner
- RNAhybrid
- 마이크로 RNA 데이터베이스
- miRBase
- DeepBase
- 마이크로 RNA 맵
- 식물 마이크로 RNA 데이터베이스(PMRD)
제4장 시장 역학
제5장 시장 내역 : 기술 유형별
- 시장 개요
- 정량적 역전사진 중합효소 연쇄반응(RT-qPCR)
- 차세대 시퀀싱(NGS)
- 마이크로어레이
- 분리 및 정제 툴
- In Situ Hybridization (ISH)/Northern Blotting
- 기타 마이크로 RNA 툴
- MicroRNA Mimics
- MicroRNA Inhibitors
- Agomirs/Antagomirs
- 시장 매출 : 기술 유형별
- RT-qPCR
- 차세대 시퀀싱(NGS)
- 마이크로어레이
- 분리 및 정제 툴
- >In Situ Hybridization (ISH)/Northern Blotting
- 기타 툴
제6장 시장 내역 : 최종사용자별
- 시장 개요
- 학술기관 및 기타 연구기관
- 생명과학 산업
- 치료
- 진단
- 마이크로 RNA 서비스 제공업체
- 시장 매출 : 최종사용자별
- 학술기관·기타 연구기관 : 기술 유형별
- 생명과학 산업 시장 : 기술 유형별
- 마이크로 RNA 서비스 제공업체 시장 : 기술 유형별
제7장 시장 내역 : 용도별
- 시장 개요
- 암
- 심혈관질환
- 신경학적 장애
- 대사성 질환
- 면역 질환
- 기타 질환
- 시장 매출 : 용도별
- 암
- 심혈관 질환
- 신경학적 장애
- 대사장애
- 면역 질환
- 기타 질환
제8장 시장 내역 : 지역별
- 시장 개요
- 시장 매출 : 지역별
- 북미
- 유럽
- 아시아태평양
- 기타 지역
제9장 ESG 전개
- ESG : 서론
- 마이크로 RNA 툴 및 서비스 업계 지속가능성 : ESG의 관점
- ESG 주요 과제
- ESG에 대한 소비자 의식
- ESG 성과 분석
- 사례 연구
- BCC의 결론
제10장 새로운 동향 및 기술
- 시장의 신기술 및 동향
- 비침습적 헬스 모니터링을 위한 순환 마이크로 RNA 진단
- 디지털 PCR(dPCR) 채택 증가
- RNA 시퀀싱
제11장 임상시험 분석
제12장 경쟁 구도
제13장 기업 개요
- ABCAM PLC
- AGILENT TECHNOLGIES INC.
- BIO-RAD LABORATORIES INC.
- CD GENOMICS
- DANAHER
- F. HOFFMANN-LA ROCHE AG
- GENECOPOEIA INC.
- ILLUMINA INC.
- MERCK KGAA
- NANOSTRING TECHNOLOGIES INC.
- QIAGEN
- REGULUS THERAPEUTICS
- THERMO FISHER SCIENTIFIC INC.
- TAKARA BIO INC.
LSH
Highlights:
The global market for microRNA (miRNA) research tools is estimated to increase from $664.2 million in 2023 to $883.0 million by 2028, at a compound annual growth rate (CAGR) of 5.9% from 2023 through 2028.
The global market for miRNA based quantitative reverse transcription PCR (RT-qPCR) is estimated to increase from $211.0 million in 2023 to $277.2 million by 2028, at a CAGR of 5.6% from 2023 through 2028.
The global market for miRNA based next-generation sequencing (NGS) technology is estimated to increase from $141.1 million in 2023 to $204.0 million by 2028, at a CAGR of 7.6% from 2023 through 2028.
Report Scope:
The research study aims to thoroughly assess and analyze the miRNA research tools, diagnostics and therapeutics market; revenue forecasts; and future trends globally and provide strategic recommendations for the success of the market participants. This study focuses on the global market of miRNA tools and provides an updated review including its applications in various arenas of diagnostics and therapeutics. The report deals with miRNA tools covering technologies used in the biomedical industry. These products are miRNA quantitative reverse transcription-PCR, next-generation sequencing, microarray, fluorescent in situ hybridization, isolation and purification tools and other tools like inhibitors, probes and vectors.
The report also covers miRNA tools by end user and application. The end users for miRNA tools are categorized as academic and other research institutes, life science industry, and service sectors. The report covers market application areas, such as cancer, cardiovascular diseases, immune diseases, neurological disorders, metabolic disorders, and others (virology, liver diseases, genetic diseases among others).
The scope of the study is global. Current and projected market forecasts during the forecast period (2023 to 2028) are discussed. Figures for 2023 are estimated, except where actual results have been reported. This report includes forecasts by technology type, end user, application and region from 2023 through 2028.
The report also includes an analysis of leading and emerging competitors in the current worldwide miRNA research tools, diagnostics and therapeutics market. Profiles of manufacturers of leading products as well as biotechnology companies with novel products in development, are analyzed to define the specific product strategies employed. This report also assesses emerging trends and technologies in the market.
Report Includes:
- 33 data tables and 43 additional tables
- An up-to-date overview and industry analysis of the global markets for microRNA (miRNA) research tools, diagnostics and therapeutics
- Analyses of the global market trends, with historical market revenue data (sales figures) for 2020-2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
- Estimation of the actual market size and revenue forecast for the global miRNA tools markets, and corresponding market share analysis based on technology type, application (therapeutic area), end user, and region
- Updated information on key market drivers and opportunities, industry shifts and regulations, and other region and industry specific macroeconomic variables that will influence this market demand in the coming years (2023-2028)
- Insight into the recent industry structure, competitive aspects of each product segments, increasing investment on R&D activities, market growth strategies, and company revenue share analysis
- Review of the selected new miRNA products, research tools and diagnostics services, recent drug candidates, clinical trial applications, and new trends and developments in the biomedical industry
- Examination of the extensive portfolio of miRNA pathway drug candidates, some already in Phase II clinical trials, showing promising clinical data in various arenas of diagnostics and therapeutics, including cancer, hepatitis infections, and cardiovascular diseases etc.
- Identification of leading and emerging competitors in the current worldwide market for miRNA research tools, diagnostics, and therapeutics, and analysis of their competitive landscape based on recent developments and segmental revenues
- Descriptive company profiles of the leading global players, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., Illumina Inc., F. Hoffmann-La Roche AG, Merck KGaA, Qiagen N.V., and Thermo Fisher Scientific Inc.
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Methodology and Information Sources
- What's New in This Update?
- Geographic Breakdown
Chapter 2 Summary and Highlights
- Market Outlook
- Highlights of the MicroRNA Research Tools, Diagnostics and Therapeutics Markets
Chapter 3 Market Overview
- Background: Genetic Material
- Types of RNA
- Messenger RNA (mRNA)
- Ribosomal RNA (rRNA)
- Transfer RNA (tRNA)
- Small Interfering RNAs (siRNA)
- Small Nucleolar RNA (snoRNA)
- PIWI-interacting RNAs (piRNAs)
- MicroRNAs (miRNAs)
- Overview
- History of MicroRNA Research
- Biogenesis of MicroRNA
- The Function of MicroRNA
- Applications of MicroRNA
- Research Tools
- MicroRNA in Therapeutics
- MicroRNA in Diagnostics
- Bioinformatics: Applications in MicroRNA Research
- Computational Tools
- miRDB
- TargetScan
- DIANA-microT-CDS
- miRTargetLink 2.0
- RNA22 v2
- TargetMiner
- RNAhybrid
- MicroRNA Databases
- miRBase
- DeepBase
- miRNAMap
- Plant microRNA Database (PMRD)
Chapter 4 Market Dynamics
- Market Drivers
- Developments in Analytical Technologies and Assay Methods
- Robust Funding Environment for Biomedical Research
- Increasing Incidence of Chronic Diseases
- Growing Number of Clinically Relevant miRNAs
- Market Challenges
- High Investment Cost
- High Failure Rate
- Challenges Associated with microRNA Based Therapeutics Development
- Lack of Skilled Professionals
Chapter 5 Market Breakdown by Technology Type
- Market Overview
- Quantitative Reverse Transcription Polymerase Chain Reaction (RT-qPCR)
- Next-Generation Sequencing (NGS)
- Microarray
- Isolation and Purification Tools
- In Situ Hybridization (ISH) and Northern Blotting
- Other miRNA Tools
- MicroRNA Mimics
- MicroRNA Inhibitors
- Agomirs/Antagomirs
- Market Revenue by Technology Type
- RT-qPCR
- Next-generation Sequencing (NGS)
- Microarray
- Isolation and Purification Tools
- In Situ Hybridization (ISH) and Northern Blotting
- Other Tools
Chapter 6 Market Breakdown by End User
- Market Overview
- Academic and Other Research Institutes
- Life Science Industry
- Therapeutics
- Diagnostics
- miRNA Service Providers
- Market Revenue by End User
- Academic and Other Research Institutes Market, by Technology Type
- Life Science Industry Market, by Technology Type
- miRNA Service Providers Market, by Technology Type
Chapter 7 Market Breakdown by Application
- Market Overview
- Cancer
- Cardiovascular Diseases
- Neurological Disorders
- Metabolic Diseases
- Immune Disorders
- Other Diseases
- Market Revenue by Application
- Cancer
- Cardiovascular Diseases
- Neurological Disorders
- Metabolic Disorders
- Immune Disorders
- Other Diseases
Chapter 8 Market Breakdown by Region
- Market Overview
- Market Revenue by Region
- North America
- Market Revenue, by Technology Type
- Europe
- Market Revenue, by Technology Type
- Asia-Pacific
- Market Revenue, by Technology Type
- Rest of the World (RoW)
- Market Revenue, by Technology Type
Chapter 9 ESG Development
- Introduction to ESG
- Sustainability in miRNA Tools and Services Industry: An ESG Perspective
- Key ESG Issues
- Consumer Attitudes Towards ESG
- Industry ESG Performance Analysis
- Case Study
- Concluding Remarks from BCC
Chapter 10 Emerging Trends and Technologies
- Emerging Technologies and Trends in the Market
- Circulating miRNA Diagnostics for Non-invasive Health Monitoring
- Increasing Adoption of Digital PCR (dPCR)
- RNA-Sequencing
Chapter 11 Clinical Trials Analysis
- Overview
- Pipeline Analysis
Chapter 12 Competitive Landscape
- Overview
- Leading Market Players Ranking
- Mergers and Acquisitions
Chapter 13 Company Profiles
- ABCAM PLC
- AGILENT TECHNOLGIES INC.
- BIO-RAD LABORATORIES INC.
- CD GENOMICS
- DANAHER
- F. HOFFMANN-LA ROCHE AG
- GENECOPOEIA INC.
- ILLUMINA INC.
- MERCK KGAA
- NANOSTRING TECHNOLOGIES INC.
- QIAGEN
- REGULUS THERAPEUTICS
- THERMO FISHER SCIENTIFIC INC.
- TAKARA BIO INC.
